Position in UTHR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$115,409
+$81,017 QoQ
Shares Held
213
+267.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#720
of 870 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $8,299,759 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
39,698 | $4,404,096 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
65,730 | $1,617,615 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,799 | $897,723 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
25,398 | $797,497 | |
| 5 | ZTS |
Zoetis Inc.
|
5,315 | $381,935 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
213 | $115,409 | |
| 7 | ALKS |
Alkermes plc.
|
700 | $36,680 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,242 | $21,499 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,409 | 213 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $34,392 | 58 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $47,750 | 98 | Shares | Sole | 2026-01-20 | |
| 2023-06-30 | $59,602 | 270 | Shares | Sole | 2023-07-11 | |
| 2022-12-31 | $87,042 | 313 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $89,405 | 427 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $197,937 | 840 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $151,063 | 842 | Shares | Sole | 2022-04-28 | |
| No filing history on record for this holder in this stock. | ||||||